Santarus Inc (NASDAQ:SNTS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendall Wierenga Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Cytokinetics, Incorporated (Director · Since at least Feb 9, 2011); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past) | EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past |
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Oncternal Therapeutics Inc (Director · Jun 7, 2019 – Jun 20, 2024 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past) | Director · Mar 21, 2012 – Jan 2, 2014 · Past |
| Michael E Herman Other companies: Senomyx Inc (Director · May 31, 2007 – May 11, 2017 · Past); Cerner Corp (Director · May 25, 2007 – May 27, 2010 · Past) | Director · Jun 14, 2007 – Jan 2, 2014 · Past |
| Maria E Bedoya-Toro Other companies: Dermata Therapeutics, Inc. (SVP, Regulatory Affairs · Since at least Aug 12, 2021) | SVP, Regulatory Affairs & QA · May 28, 2007 – Jan 2, 2014 · Past |
| Julie A De Meules | Sr. VP, Human Resources · Feb 9, 2006 – Jan 2, 2014 · Past |
| Mark Totoritis | SVP, Clinical Research · Mar 12, 2012 – Jan 2, 2014 · Past |